We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Arthritis Risk Falls as Omega-3 Intake Rises

By HospiMedica International staff writers
Posted on 27 Aug 2013
A diet rich in omega-3 fatty acids protects against rheumatoid arthritis (RA) in women, according to a new study.

Researchers at the Karolinska Institute (Stockholm, Sweden) collected data on diet via a self-administered food-frequency questionnaire (FFQ) to analyze the association between dietary long-chain n-3 polyunsaturated fatty acids (PUFAs) and fish intake, and incidence of RA in 32,232 middle-aged and older women from the Swedish Mammography Cohort, a population-based prospective study. More...
The risk of RA was estimated using Cox proportional hazard regression models, adjusted for age, cigarette smoking, alcohol intake, use of aspirin, and energy intake.

The results showed that 205 RA cases were identified during a mean follow-up of 7.5 years. An intake of dietary long-chain n-3 PUFAs of more than 0.21 g/day was associated with a 35% decreased risk of developing RA, compared with a lower intake. Long-term intake consistently higher than 0.21 g/day was associated with a 52% decreased risk. The researchers also found that consistent long-term consumption of more than one fish serving per week was associated with a 29% decrease in risk. The study was published online on August 12, 2013, in Annals of Rheumatic Diseases.

“The study indicates a potentially important role for dietary long-chain n-3 polyunsaturated fatty acids in the etiology of RA, and that adherence to existing dietary guidelines regarding fish consumption may also be beneficial in terms of RA risk,” concluded lead author Alicja Wolk, MD, and colleagues of the Institute of Environmental Medicine.

Omega-3 fatty acids refer to a group of three fats called α-linolenic acid (ALA, found in plant oils), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), both commonly found in marine oils. Omega-3 fatty acids are vital for normal metabolism and are therefore considered essential fatty acids, meaning that they cannot be synthesized by the human body. A growing body of literature suggests that higher intakes Omega-3 fatty acids may afford some degree of protection against coronary disease.

Related Links:

Karolinska Institute



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.